Related references
Note: Only part of the references are listed.Mechanism of low-molecular-weight heparin reversal by platelet factor 4
Martine M. Fiore et al.
THROMBOSIS RESEARCH (2009)
Hemorrhagic complications of anticoagulant and thrombolytic treatment
Sam Schulman et al.
CHEST (2008)
Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats
B. Lauritzen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Successful management of bleeding with recombinant factor Vila (NovoSeven®) in a patient with Burkitt lymphoma and thrombosis of the left femoral and left common iliac veins
Srdana Culic et al.
PEDIATRIC BLOOD & CANCER (2007)
Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation
G. T. Gerotziafas et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Recombinant activated factor VII treatment of retroperitoneal hematoma in a patient with renal failure receiving enoxaparin and clopidogrel
Antoine Cherfan et al.
PHARMACOTHERAPY (2007)
Use of recombinant factor VIIa for emergency reversal of anticoagulation
J. Ingerslev et al.
JOURNAL OF POSTGRADUATE MEDICINE (2007)
Reversal of low-molecular-weight heparin-induced bleeding in patients with pre-existing hypercoagulable states with human recombinant activated factor VII concentrate
Kashif Firozvi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Incomplete reversal of enoxaparin toxicity by protamine: Implications of renal insufficiency, obesity, and low molecular weight heparin sulfate content
LS Chawla et al.
OBESITY SURGERY (2004)
Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and in rats in vivo
BP Schick et al.
BLOOD (2004)
Assessment of recombinant factor VIIa as an antidote for bleeding induced in the rabbit by low molecular weight heparin
S Chan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Acute subdural haematomas and enoxaparin
S Olson et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2002)
Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin
MA Crowther et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Enoxaparin-associated severe retroperitoneal bleeding and abdominal compartment syndrome: a report of two cases
A Dabney et al.
INTENSIVE CARE MEDICINE (2001)
Poor reversal of low molecular weight heparin by protamine
M Makris et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
